Atlas Trials

Rivastigmine in the Management of Delirium

Clinical trial NCT01487317 · COMPLETED

Trial details

NCT number
NCT01487317
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Delirium
Start date
2011-06-01
Primary completion
2015-08-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.